This inventor holds 0 USPTO granted patents, plus 9 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Karl Malcolm: Innovator in Intravaginal Drug Delivery Devices
Introduction
Karl Malcolm is a notable inventor based in Great Britain, recognized for his contributions to the field of drug delivery systems. He has focused on developing innovative devices that enhance the administration of pharmaceuticals, particularly in the intravaginal space. Despite having no patents registered under his name, his work has significant implications for medical technology.
Latest Patents
Karl Malcolm's latest inventions include two notable intravaginal drug delivery devices. The first device comprises a body made of hydrophobic carrier material with a channel designed to receive drug-containing inserts. This device allows for the release of a pharmaceutically effective amount of drugs suitable for intravaginal administration, incorporating a water-soluble release enhancer. The second device features at least one reservoir containing pharmacologically active agents, surrounded by a sheath with openings that expose the reservoir to the vaginal environment during use. These innovations aim to improve the efficacy and convenience of drug delivery.
Career Highlights
Throughout his career, Karl Malcolm has worked with prominent companies in the pharmaceutical industry, including Warner Chilcott Company, LLC and Warner Chilcott, LLC. His experience in these organizations has contributed to his expertise in developing advanced drug delivery systems.
Collaborations
Karl has collaborated with various professionals in the field, including David Woolfson, to enhance the development of his innovative devices.
Conclusion
Karl Malcolm's work in intravaginal drug delivery devices showcases his commitment to advancing pharmaceutical technology. His innovative approaches have the potential to significantly impact the way medications are administered, improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile